Group B Streptococcus (GBS), or beta strep, is a normal bacterium commonly found in the intestinal tract along with other healthy bacteria. It is a transient bacterial colonization present intermittently throughout a woman's life. When present during pregnancy, women should more accurately be termed "GBS colonized" rather than "GBS infected", as its presence in the intestinal tract is normal.
The American College of Obstetricians and Gynecologists (ACOG) and the US Centers for Disease Control and Prevention (CDC) recommend that all pregnant women be screened between 35 and 37 weeks to determine if they are carriers of GBS by taking a swab of the vaginal and rectal areas. About 30% of pregnant women are found to be colonized with GBS in one or both areas.
GBS can cause problems, such as sepsis (a blood infection), pneumonia, and/or meningitis (an infection of the fluid and lining of the brain), when it is transmitted from the mother to the baby, usually during labor. However, research has shown GBS can also be transmitted prenatally across the amniotic membranes, sometimes through invasive procedures such as cervical exams, membrane stripping, internal fetal monitoring or during the application of cervical ripeners for induction. When any of these conditions occur, there is a small risk that the bacteria will be passed to the baby, causing it to become sick.
There are two recognized forms of Group B Streptococcus infection: early and late onset. A third type, prenatal onset, occurs when the bacteria crosses the amniotic membranes prenatally and can result in early or late pregnancy miscarriage or stillbirth. It is not yet known how many babies are affected in this manner.
Of these, the most prevalent form is early onset. In early-onset GBS disease, babies will become ill within seven days of birth. In severe early-onset GBS infection, about 6 percent of babies will die from complications of the infection. Full-term babies are less likely to die; 2-8% suffer fatal complications. Premature babies have mortality rates of 25-30%. Late-onset GBS infection is more complicated and may not be related to the mother's GBS status. It occurs between seven days and three months of age.
Symptoms of early-onset Group B Streptococcus infection include any of the following: fever or abnormally low body temperature, jaundice (yellowing of the skin and whites of the eyes), poor feeding, vomiting, seizures, difficulty in breathing, swelling of the abdomen, and bloody stools. The most common symptom is difficulty breathing, which is also the most common complication in babies whose mothers chose drugs during labor. Since these symptoms can occur in so many circumstances unrelated to GBS, a C-Reactive protein test can be given to a symptomatic baby to reveal the presence of an active infection.
There are three significant factors that place babies at increased risk of infection: fever during labor, water breaking 18 hours or more before birth (prolonged rupture of membranes, or PROM), and/or labor or broken water before 37 weeks. Other factors that can contribute to a newborn's risk of contracting Group B Streptococcus infection include age, ethnicity, and medical criteria, such as the following: being born to a mother who is less than 20 years old, being African American, a high colonization of GBS bacteria, and having had a previous baby with GBS disease.
The recommended treatment by the CDC and ACOG is intravenous antibiotics during labor for all women who swab positive during their pregnancies without regard to the concentration of colonization present. While this practice has been successful in reducing the rate of early-onset infection from 0.7 cases per 1000 live births in the U.S. in 1997 to 0.32 cases per 1000 live births in the U.S. in 2004, it has not affected the number of babies who will die from early or late onset GBS disease. Furthermore, the use of intrapartum antibiotics has not been found to be evidence-based in a meta analysis conducted by the Cochrane Collaboration.
Two in 10,000 babies may be saved by antibiotics during birth, but this comes at the cost of giving 1/3 of all pregnant women antibiotics. There are many reasons women may not want antibiotics for Group B Streptococcus. These include:
The most-commonly used antibiotic for treating Group B Streptococcus during labor is penicillin. Fewer bacteria currently show a resistance to penicillin than to other antibiotics used to treat GBS. It’s only a matter of time until penicillin is also ineffective against GBS.
If allergic to penicillin, options decrease. 29% of Group B Streptococcus strains are resistant to non-penicillin antibiotics. There's a 1/10 chance of a mild reaction such as a rash, and a 1/10,000 chance of anaphylaxis, a life-threatening allergic reaction to penicillin, even for those who've taken it previously. Reactions can start or strengthen in severity during pregnancy.
Even though Group B Streptococcus colonization is transient, without an active effort to eradicate the GBS colonization, it is likely that women will still be colonized after 37 weeks. The degree and location of colonization, especially if present in the mother's urine, which is not routinely tested, is a more reliable indicator of transmission risk. Unfortunately, these factors are not considered within the universal treatment protocol. Better outcomes can be attained by focusing on first reducing colonization rather than only treating it after the fact.
There are probiotic approaches that focus on restoring a healthy vaginal flora balance, reducing bacterial overgrowth, and directly reducing the bacterial concentration. Alternative options focus on:
Unfortunately, limited research has been conducted on minimizing colonization, opting instead for intrapartum antibiotics after a positive culture despite the unfavorable research evidence.
Another option is to not screen for beta strep during pregnancy, but to follow a strict protocol during birthing if any of the following risk factors are present: 1) fever over 38 degrees Celsius, 2) pre-term birthing < 37 weeks, 3) prolonged rupture of membranes > 18 hours, 4) multiple births, and 5) previously-infected baby. In these cases antibiotics may be indicated. Those infants who are symptomatic (fever, fast breathing, poor feeding, high pitched cry) can be evaluated for sepsis and given antibiotics for 48-72 hours. Alternately, a C-reactive protein test can be performed to determine the presence of an active infection before giving antibiotics to the baby.
After assessing risk factors and deciding upon a plan of action, it can be added either in the body of a birth plan or as an addendum. Here is sample language that may be included:
I (will/will not) be screened for Group B Streptococcus.
If the result is negative, the only precautions will be to closely monitor labor for the above risk factors and monitor the baby after childbirth for possible signs of infection.
If any of the risk factors (fever over 38 degrees Celsius, pre-term birthing < 37 weeks, prolonged rupture of membranes > 18 hours) occur, mother will consent to ___________.
If the result is positive the treatment of choice is :_______
Mother’s Signature Date Care Provider‘s Signature Date
Page Last Modified by Catherine Beier, MS, CBE
Choose 7 week, 12 week, or Self- Paced online childbirth classes available wherever and whenever you need them.
Vanessa's natural birth story shows that when birth is left alone to proceed as it should, it waits for no one - not even doctors or midwives.
Create a free pregnancy ticker to post on your blog, website, Facebook profile or favorite social media...